Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Successful completion of phase Ib study for DSC-104 in asthma

March 12, 2004

Kos to acquire Azmacort franchise

March 12, 2004

Patient enrollment completed for a phase IV trial with Spiriva

March 11, 2004

Foradil Certihaler receives Swiss approval

March 10, 2004

Antiinflammatory effects of the PDE4 inhibitor AWD-12-281 shown in human cell preparations

March 10, 2004

AstraZeneca team develops new CXCR2 modulators for asthma, rhinitis, COPD, etc.

March 9, 2004

JNJ-7777120, a potent histamine H4 receptor antagonist with antiinflammatory activity

March 9, 2004

Japanese approval for Serevent 50 Diskus

March 8, 2004

Sinus and Allergy Health Partnership guidelines recommend Omnicef

March 3, 2004

Successful completion of first phase I trial for nebulized rAAT

March 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...